Galcanezumab-Gnlm
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Galcanezumab-Gnlm is used to treat cluster headache, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $305 million on Galcanezumab-Gnlm across 349,000 claims for 61,000 beneficiaries.
Galcanezumab-Gnlm is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $612.59 to $734.53 per ML — a 20% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$612.59 – $734.53
per ML
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing GALCANEZUMAB-GNLM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EMGALITY 120 MG/ML SYRINGE | $734.5303 per ML | +0.06% |
EMGALITY 120 MG/ML PEN | $734.2237 per ML | 0.00% |
EMGALITY 300 MG DOSE (100 MG/ML X 3 SYRINGES) | $612.5901 per ML | +0.02% |
Frequently Asked Questions
What is Galcanezumab-Gnlm used to treat?
Galcanezumab-Gnlm is used to treat cluster headache, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Galcanezumab-Gnlm?
In 2024, Medicare Part D spent $305 million on Galcanezumab-Gnlm across 349,000 claims for 61,000 beneficiaries.
How many Galcanezumab-Gnlm products are on the market?
The Galcanezumab-Gnlm drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Galcanezumab-Gnlm?
NADAC reference prices for Galcanezumab-Gnlm range from $612.5901 to $734.5303 per ML — a 20% difference between cheapest and most expensive.
Which manufacturers make Galcanezumab-Gnlm?
1 manufacturer lists Galcanezumab-Gnlm in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (3).
How has the price of Galcanezumab-Gnlm changed recently?
Over the past 7 days, 2 Galcanezumab-Gnlm NDCs rose and 0 fell, with a market-wide average change of +0.0%.